Department. of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Surgery and Urology, Danderyd Hospital, Stockholm, Sweden.
Department of Surgery, Södersjukhuset, Stockholm, Sweden; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
Eur J Surg Oncol. 2021 Sep;47(9):2398-2404. doi: 10.1016/j.ejso.2021.05.008. Epub 2021 May 14.
Multidisciplinary team (MDT) assessment is associated with improved survival in locally advanced rectal cancer, but the effect of an MDT assessment on survival in locally advanced colon cancer has not been reported. The aim of this national population-based cohort study was to establish if preoperative MDT assessment affects prognosis in patients with primary locally advanced colon cancer.
All patients in Sweden with locally advanced colon cancer, without metastatic disease, who underwent an elective colon resection between 2010 and 2017 were identified through the Swedish Colorectal Cancer Registry (SCRCR), and the cohort was linked to national registers. Data on patient characteristics, preoperative staging, surgical procedures, recurrence and survival were collected from SCRCR. The association between MDT assessment and colon cancer-specific survival was evaluated using Kaplan-Meier survival curves and Cox proportional hazards models. The multivariable analysis was adjusted for sex, age, ASA grade, CCI, time period, pN, region and preoperative MDT.
MDT assessment was performed in 2663 patients (84.4%) of 3157 eligible patients. The 3-year colon cancer-specific survival was higher following MDT, compared with no MDT assessment (80% versus 68%). MDT assessment was independently associated with reduced colon cancer-specific mortality (HR 0.70, 0.57-0.84 95% CI).
Preoperative MDT assessment is associated with an improved long-term survival in patients with locally advanced colon cancer and should be mandatory in patients with suspected locally advanced colon cancer.
多学科团队(MDT)评估与局部晚期直肠癌患者的生存改善相关,但 MDT 评估对局部晚期结肠癌患者的生存影响尚未报道。本项全国性基于人群的队列研究旨在确定术前 MDT 评估是否会影响原发性局部晚期结肠癌患者的预后。
通过瑞典结直肠癌登记处(SCRCR)确定 2010 年至 2017 年间接受择期结肠切除术且无转移疾病的所有瑞典局部晚期结肠癌患者,并将该队列与国家登记处进行了关联。从 SCRCR 中收集了患者特征、术前分期、手术程序、复发和生存数据。使用 Kaplan-Meier 生存曲线和 Cox 比例风险模型评估 MDT 评估与结肠癌特异性生存之间的关联。多变量分析调整了性别、年龄、ASA 分级、CCI、时间范围、pN、区域和术前 MDT。
在 3157 名符合条件的患者中,有 2663 名(84.4%)患者接受了 MDT 评估。与无 MDT 评估相比,接受 MDT 评估的患者 3 年结肠癌特异性生存率更高(80%对 68%)。MDT 评估与结肠癌特异性死亡率降低独立相关(HR 0.70,0.57-0.84;95%CI)。
术前 MDT 评估与局部晚期结肠癌患者的长期生存改善相关,对于疑似局部晚期结肠癌的患者,术前 MDT 评估应作为常规。